- Home
- SBLX vs ISPC Comparison
SBLX vs ISPC Comparison
Compare SBLX & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBLX
- ISPC
- Stock Information
- Founded
- SBLX 2017
- ISPC 2009
- Country
- SBLX United States
- ISPC United States
- Employees
- SBLX N/A
- ISPC 24
- Industry
- SBLX Telecommunications Equipment
- ISPC Precision Instruments
- Sector
- SBLX Consumer Discretionary
- ISPC Health Care
- Exchange
- SBLX Nasdaq
- ISPC Nasdaq
- Market Cap
- SBLX 6.0M
- ISPC 5.7M
- IPO Year
- SBLX N/A
- ISPC 2021
- Fundamental
- Price
- SBLX $2.70
- ISPC $0.54
- Analyst Decision
- SBLX
- ISPC
- Analyst Count
- SBLX 0
- ISPC 0
- Target Price
- SBLX N/A
- ISPC N/A
- AVG Volume (30 Days)
- SBLX 79.8K
- ISPC 216.8K
- Earning Date
- SBLX 11-14-2025
- ISPC 11-17-2025
- Dividend Yield
- SBLX N/A
- ISPC N/A
- EPS Growth
- SBLX N/A
- ISPC N/A
- EPS
- SBLX N/A
- ISPC N/A
- Revenue
- SBLX N/A
- ISPC $3,352,744.00
- Revenue This Year
- SBLX N/A
- ISPC $35.93
- Revenue Next Year
- SBLX N/A
- ISPC N/A
- P/E Ratio
- SBLX N/A
- ISPC N/A
- Revenue Growth
- SBLX N/A
- ISPC N/A
- 52 Week Low
- SBLX $2.50
- ISPC $0.53
- 52 Week High
- SBLX $15.28
- ISPC $4.90
- Technical
- Relative Strength Index (RSI)
- SBLX 29.13
- ISPC 31.72
- Support Level
- SBLX $3.10
- ISPC $0.56
- Resistance Level
- SBLX $3.96
- ISPC $0.67
- Average True Range (ATR)
- SBLX 0.47
- ISPC 0.06
- MACD
- SBLX -0.07
- ISPC 0.00
- Stochastic Oscillator
- SBLX 11.52
- ISPC 16.94
About SBLX StableX Technologies Inc. Common Stock
StableX Technologies Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.